The clinical laboratory services market is entering a phase of sustained expansion, fueled by evolving healthcare dynamics, ...
Analysts are estimating that Quest Diagnostics will report an earnings per share (EPS) of $2.51. Anticipation surrounds Quest ...
Previously, this blog covered the FDA’s decision to regulate lab-developed tests (LDTs) as medical devices.  However, ...
Quest Diagnostics DGX is set to release its third-quarter 2025 results on Oct. 21, before the market opens. The renowned ...
Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $210 from $190 and keeps an Outperform rating on the shares as part of a Q3 ...
Return to Player (RTP) has become the single most important metric for informed slot players in 2025. As the US online casino ...